Time-Dependent Changes in Hepatic Sphingolipid Accumulation and PI3K/Akt/mTOR Signaling Pathway in a Rat Model of NAFLD.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
19 Nov 2021
Historique:
received: 22 10 2021
revised: 16 11 2021
accepted: 18 11 2021
entrez: 27 11 2021
pubmed: 28 11 2021
medline: 21 12 2021
Statut: epublish

Résumé

Increased lipid bioavailability in a diet favors lipid accumulation, enhancing hepatic lipotoxicity and contributing to insulin resistance (IR) development. The aim of our study was to examine time-dependent alterations in the intrahepatic content of sphingolipids and insulin signaling pathway in rats fed a high-fat diet (HFD). The experiment was conducted on male Wistar rats receiving a standard diet or HFD for five weeks. At the end of each experimental feeding week, liver sphingolipids were determined using high-performance liquid chromatography. The expression of proteins from the sphingolipid pathway and glucose transporter expression were assessed by Western blot. The content of phosphorylated form of proteins from the insulin pathway was detected by a multiplex assay kit. Our results revealed that HFD enhanced hepatic ceramide deposition by increasing the expression of selected proteins from sphingomyelin and salvage pathways in the last two weeks. Importantly, we observed a significant inhibition of Akt phosphorylation in the first week of HFD and stimulation of PTEN and mTOR phosphorylation at the end of HFD. These changes worsened the PI3K/Akt/mTOR signaling pathway. We may postulate that HFD-induced reduction in the insulin action in the time-dependent matter was exerted by excessive accumulation of sphingosine and sphinganine rather than ceramide.

Identifiants

pubmed: 34830360
pii: ijms222212478
doi: 10.3390/ijms222212478
pmc: PMC8618899
pii:
doi:

Substances chimiques

Insulin 0
Sphingolipids 0
Proto-Oncogene Proteins c-akt EC 2.7.11.1
TOR Serine-Threonine Kinases EC 2.7.11.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Medical University of Bialystok
ID : SUB/1/DN/19/001/1118

Références

Hepatology. 2015 Jul;62(1):135-46
pubmed: 25808625
Hepatology. 2007 Oct;46(4):1081-90
pubmed: 17654743
Mol Med Rep. 2010 Nov-Dec;3(6):909-15
pubmed: 21472332
Biochim Biophys Acta Mol Basis Dis. 2019 Jan;1865(1):14-25
pubmed: 30300671
Mediators Inflamm. 2015;2015:520618
pubmed: 26648664
Int J Mol Sci. 2019 Aug 05;20(15):
pubmed: 31387306
Mol Cell Biochem. 2010 Jul;340(1-2):125-31
pubmed: 20174962
J Biol Chem. 2007 Jul 20;282(29):21327-36
pubmed: 17540768
Diabetologia. 2007 Apr;50(4):891-900
pubmed: 17265031
Liver Int. 2020 Apr;40(4):844-859
pubmed: 31883408
Hepatology. 2015 Apr;61(4):1216-26
pubmed: 25363242
Mol Cells. 2020 May 31;43(5):419-430
pubmed: 32392908
Endocrinology. 2005 Mar;146(3):1473-81
pubmed: 15604215
Prog Lipid Res. 2017 Apr;66:14-29
pubmed: 28104532
Int J Mol Sci. 2012;13(2):2276-89
pubmed: 22408453
Int Rev Cell Mol Biol. 2013;301:291-358
pubmed: 23317821
Cell Signal. 2008 Jun;20(6):1010-8
pubmed: 18191382
Prostaglandins Other Lipid Mediat. 2010 Nov;93(3-4):75-83
pubmed: 20599517
Hepatology. 2013 Feb;57(2):525-32
pubmed: 22911490
Sci Rep. 2018 May 8;8(1):7249
pubmed: 29739997
Pflugers Arch. 2020 Sep;472(9):1273-1298
pubmed: 32591906
Jacobs J Diabetes Endocrinol. 2016 Dec;2(1):
pubmed: 29130078
Biochim Biophys Acta. 2014 Nov;1842(11):2329-2343
pubmed: 25128743
Oncotarget. 2015 Oct 13;6(31):31916-26
pubmed: 26376616
Gastroenterology. 2018 Aug;155(2):282-302.e8
pubmed: 29906416
J Alzheimers Dis. 2009;16(4):715-29
pubmed: 19387108
J Clin Endocrinol Metab. 2006 Dec;91(12):4753-61
pubmed: 16968800
Cell Physiol Biochem. 2015;37(3):1147-58
pubmed: 26402523
Int J Clin Exp Pathol. 2018 May 01;11(5):2440-2449
pubmed: 31938356
J Clin Med. 2021 Feb 16;10(4):
pubmed: 33669443
Basic Res Cardiol. 2013 Sep;108(5):369
pubmed: 23836256
Trends Biochem Sci. 2006 Jun;31(6):342-8
pubmed: 16679021
Liver Int. 2014 Aug;34(7):1074-83
pubmed: 24106929
J Biol Chem. 1993 Dec 25;268(36):27299-306
pubmed: 8262970
Sci Rep. 2017 Mar 16;7:44819
pubmed: 28300221
Biochimie. 2019 Apr;159:9-22
pubmed: 30071259
Biomed Res Int. 2020 Jul 18;2020:4020249
pubmed: 32733940
Nutrients. 2021 Sep 28;13(10):
pubmed: 34684414
Mol Med Rep. 2017 Jul;16(1):109-118
pubmed: 28534956
Am J Physiol Endocrinol Metab. 2016 Apr 1;310(7):E484-94
pubmed: 26814015
Science. 2000 Jun 16;288(5473):2045-7
pubmed: 10856218
Free Radic Biol Med. 2019 Nov 20;144:293-309
pubmed: 31152791
Aging Cell. 2014 Dec;13(6):1001-11
pubmed: 25139155
Cell Signal. 2014 Jul;26(7):1400-8
pubmed: 24650522

Auteurs

Klaudia Sztolsztener (K)

Department of Physiology, Medical University of Bialystok, 15-089 Bialystok, Poland.

Karolina Konstantynowicz-Nowicka (K)

Department of Physiology, Medical University of Bialystok, 15-089 Bialystok, Poland.

Ewa Harasim-Symbor (E)

Department of Physiology, Medical University of Bialystok, 15-089 Bialystok, Poland.

Adrian Chabowski (A)

Department of Physiology, Medical University of Bialystok, 15-089 Bialystok, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH